vs
APi Group Corp（APG）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
APi Group Corp的季度营收约是瑞思迈的1.5倍（$2.1B vs $1.4B），瑞思迈净利率更高（27.6% vs 4.6%，领先23.0%），瑞思迈同比增速更快（11.0% vs 10.6%），APi Group Corp自由现金流更多（$356.0M vs $311.2M），过去两年APi Group Corp的营收复合增速更高（10.6% vs 9.0%）
xAI是埃隆·马斯克2023年创立的美国科技企业，为航天企业SpaceX的全资子公司，业务覆盖人工智能、社交媒体领域，核心产品包括生成式AI聊天机器人Grok，以及2025年3月收购的社交媒体平台X。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
APG vs RMD — 直观对比
营收规模更大
APG
是对方的1.5倍
$1.4B
营收增速更快
RMD
高出0.4%
10.6%
净利率更高
RMD
高出23.0%
4.6%
自由现金流更多
APG
多$44.8M
$311.2M
两年增速更快
APG
近两年复合增速
9.0%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.1B | $1.4B |
| 净利润 | $97.0M | $392.6M |
| 毛利率 | 32.0% | 61.8% |
| 营业利润率 | 7.7% | 34.6% |
| 净利率 | 4.6% | 27.6% |
| 营收同比 | 10.6% | 11.0% |
| 净利润同比 | — | 13.9% |
| 每股收益（稀释后） | $-1.19 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APGRMD
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $1.4B | ||
| Q3 25 | $2.1B | $1.3B | ||
| Q2 25 | $2.0B | $1.3B | ||
| Q1 25 | $1.7B | $1.3B | ||
| Q4 24 | $1.9B | $1.3B | ||
| Q3 24 | $1.8B | $1.2B | ||
| Q2 24 | $1.7B | $1.2B |
净利润APGRMD
| Q1 26 | $97.0M | — | ||
| Q4 25 | $97.0M | $392.6M | ||
| Q3 25 | $93.0M | $348.5M | ||
| Q2 25 | $77.0M | $379.7M | ||
| Q1 25 | $35.0M | $365.0M | ||
| Q4 24 | $67.0M | $344.6M | ||
| Q3 24 | $69.0M | $311.4M | ||
| Q2 24 | $69.0M | $292.2M |
毛利率APGRMD
| Q1 26 | 32.0% | — | ||
| Q4 25 | 32.0% | 61.8% | ||
| Q3 25 | 31.3% | 61.5% | ||
| Q2 25 | 30.9% | 60.8% | ||
| Q1 25 | 31.5% | 59.3% | ||
| Q4 24 | 30.9% | 58.6% | ||
| Q3 24 | 31.1% | 58.6% | ||
| Q2 24 | 31.4% | 58.5% |
营业利润率APGRMD
| Q1 26 | 7.7% | — | ||
| Q4 25 | 7.7% | 34.6% | ||
| Q3 25 | 7.8% | 33.4% | ||
| Q2 25 | 7.2% | 33.7% | ||
| Q1 25 | 4.9% | 33.0% | ||
| Q4 24 | 6.2% | 32.5% | ||
| Q3 24 | 7.8% | 31.6% | ||
| Q2 24 | 7.3% | 31.2% |
净利率APGRMD
| Q1 26 | 4.6% | — | ||
| Q4 25 | 4.6% | 27.6% | ||
| Q3 25 | 4.5% | 26.1% | ||
| Q2 25 | 3.9% | 28.2% | ||
| Q1 25 | 2.0% | 28.3% | ||
| Q4 24 | 3.6% | 26.9% | ||
| Q3 24 | 3.8% | 25.4% | ||
| Q2 24 | 4.0% | 23.9% |
每股收益（稀释后）APGRMD
| Q1 26 | $-1.19 | — | ||
| Q4 25 | $-1.16 | $2.68 | ||
| Q3 25 | $0.20 | $2.37 | ||
| Q2 25 | $0.16 | $2.58 | ||
| Q1 25 | $0.11 | $2.48 | ||
| Q4 24 | $0.05 | $2.34 | ||
| Q3 24 | $0.23 | $2.11 | ||
| Q2 24 | $0.22 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $912.0M | $1.4B |
| 总债务越低越好 | $2.8B | $403.9M |
| 股东权益账面价值 | $3.4B | $6.3B |
| 总资产 | $8.9B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.81× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资APGRMD
| Q1 26 | $912.0M | — | ||
| Q4 25 | $912.0M | $1.4B | ||
| Q3 25 | $555.0M | $1.4B | ||
| Q2 25 | $432.0M | $1.2B | ||
| Q1 25 | $460.0M | $932.7M | ||
| Q4 24 | $499.0M | $521.9M | ||
| Q3 24 | $487.0M | $426.4M | ||
| Q2 24 | $324.0M | $238.4M |
总债务APGRMD
| Q1 26 | $2.8B | — | ||
| Q4 25 | $2.8B | $403.9M | ||
| Q3 25 | $2.8B | $408.7M | ||
| Q2 25 | $2.8B | $658.4M | ||
| Q1 25 | $2.8B | $663.1M | ||
| Q4 24 | $2.8B | $662.9M | ||
| Q3 24 | $2.9B | $667.6M | ||
| Q2 24 | $2.8B | $697.3M |
股东权益APGRMD
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | $6.3B | ||
| Q3 25 | $3.3B | $6.1B | ||
| Q2 25 | $3.2B | $6.0B | ||
| Q1 25 | $3.0B | $5.5B | ||
| Q4 24 | $3.0B | $5.3B | ||
| Q3 24 | $3.0B | $5.2B | ||
| Q2 24 | $2.8B | $4.9B |
总资产APGRMD
| Q1 26 | $8.9B | — | ||
| Q4 25 | $8.9B | $8.5B | ||
| Q3 25 | $8.7B | $8.3B | ||
| Q2 25 | $8.5B | $8.2B | ||
| Q1 25 | $8.1B | $7.6B | ||
| Q4 24 | $8.2B | $7.1B | ||
| Q3 24 | $8.2B | $7.2B | ||
| Q2 24 | $8.0B | $6.9B |
负债/权益比APGRMD
| Q1 26 | 0.81× | — | ||
| Q4 25 | 0.81× | 0.06× | ||
| Q3 25 | 0.84× | 0.07× | ||
| Q2 25 | 0.87× | 0.11× | ||
| Q1 25 | 0.92× | 0.12× | ||
| Q4 24 | 0.93× | 0.13× | ||
| Q3 24 | 0.96× | 0.13× | ||
| Q2 24 | 1.00× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $759.0M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $356.0M | $311.2M |
| 自由现金流率自由现金流/营收 | 16.8% | 21.9% |
| 资本支出强度资本支出/营收 | — | 2.0% |
| 现金转化率经营现金流/净利润 | 7.82× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $969.0M | $1.8B |
8季度趋势，按日历期对齐
经营现金流APGRMD
| Q1 26 | $759.0M | — | ||
| Q4 25 | $382.0M | $339.7M | ||
| Q3 25 | $232.0M | $457.3M | ||
| Q2 25 | $83.0M | $538.8M | ||
| Q1 25 | $62.0M | $578.7M | ||
| Q4 24 | $283.0M | $308.6M | ||
| Q3 24 | $220.0M | $325.5M | ||
| Q2 24 | $110.0M | $440.1M |
自由现金流APGRMD
| Q1 26 | $356.0M | — | ||
| Q4 25 | $356.0M | $311.2M | ||
| Q3 25 | $201.0M | $414.4M | ||
| Q2 25 | $56.0M | $508.2M | ||
| Q1 25 | $50.0M | $557.9M | ||
| Q4 24 | $265.0M | $288.0M | ||
| Q3 24 | $198.0M | $307.7M | ||
| Q2 24 | $88.0M | $415.2M |
自由现金流率APGRMD
| Q1 26 | 16.8% | — | ||
| Q4 25 | 16.8% | 21.9% | ||
| Q3 25 | 9.6% | 31.0% | ||
| Q2 25 | 2.8% | 37.7% | ||
| Q1 25 | 2.9% | 43.2% | ||
| Q4 24 | 14.2% | 22.5% | ||
| Q3 24 | 10.8% | 25.1% | ||
| Q2 24 | 5.1% | 33.9% |
资本支出强度APGRMD
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 2.0% | ||
| Q3 25 | 1.5% | 3.2% | ||
| Q2 25 | 1.4% | 2.3% | ||
| Q1 25 | 0.7% | 1.6% | ||
| Q4 24 | 1.0% | 1.6% | ||
| Q3 24 | 1.2% | 1.5% | ||
| Q2 24 | 1.3% | 2.0% |
现金转化率APGRMD
| Q1 26 | 7.82× | — | ||
| Q4 25 | 3.94× | 0.87× | ||
| Q3 25 | 2.49× | 1.31× | ||
| Q2 25 | 1.08× | 1.42× | ||
| Q1 25 | 1.77× | 1.59× | ||
| Q4 24 | 4.22× | 0.90× | ||
| Q3 24 | 3.19× | 1.05× | ||
| Q2 24 | 1.59× | 1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APG
暂无分部数据
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
